AI assistant
Sending…
Larimar Therapeutics, Inc. — Director's Dealing 2017
Oct 11, 2017
33359_dirs_2017-10-11_a1341375-9951-4cc5-9d1b-1160c12b3d00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2017-10-09
Reporting Person: Hatfield Jeffrey S. (Director, Chief Executive Officer)
More from Larimar Therapeutics, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2